[go: up one dir, main page]

WO2007117272A3 - Méthodes de traitement d'un choc hémorragique et de troubles associés - Google Patents

Méthodes de traitement d'un choc hémorragique et de troubles associés Download PDF

Info

Publication number
WO2007117272A3
WO2007117272A3 PCT/US2006/038164 US2006038164W WO2007117272A3 WO 2007117272 A3 WO2007117272 A3 WO 2007117272A3 US 2006038164 W US2006038164 W US 2006038164W WO 2007117272 A3 WO2007117272 A3 WO 2007117272A3
Authority
WO
WIPO (PCT)
Prior art keywords
hemorrhagic shock
treatment
methods
related disorders
cardiopulmonary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2006/038164
Other languages
English (en)
Other versions
WO2007117272A9 (fr
WO2007117272A2 (fr
Inventor
Elena V Koustova
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henry M Jackson Foundation for Advancedment of Military Medicine Inc
Original Assignee
Henry M Jackson Foundation for Advancedment of Military Medicine Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henry M Jackson Foundation for Advancedment of Military Medicine Inc filed Critical Henry M Jackson Foundation for Advancedment of Military Medicine Inc
Priority to EP06850512A priority Critical patent/EP1940379A4/fr
Publication of WO2007117272A2 publication Critical patent/WO2007117272A2/fr
Publication of WO2007117272A9 publication Critical patent/WO2007117272A9/fr
Anticipated expiration legal-status Critical
Publication of WO2007117272A3 publication Critical patent/WO2007117272A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne l'utilisation de certains agents pour le traitement d'un choc hémorragique et des opérations chirurgicales faisant appel à une machine de circulation extracorporelle. La présente invention concerne également des méthodes de prévention, de traitement, d'administration et de préparation d'agents destinés à prévenir et/ou atténuer une lésion cellulaire et tissulaire associée à un choc hémorragique et à des opérations chirurgicales faisant appel à une machine de circulation extracorporelle.
PCT/US2006/038164 2005-09-30 2006-10-02 Méthodes de traitement d'un choc hémorragique et de troubles associés Ceased WO2007117272A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP06850512A EP1940379A4 (fr) 2005-09-30 2006-10-02 Méthodes de traitement d'un choc hémorragique et de troubles associés

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72197905P 2005-09-30 2005-09-30
US60/721,979 2005-09-30

Publications (3)

Publication Number Publication Date
WO2007117272A2 WO2007117272A2 (fr) 2007-10-18
WO2007117272A9 WO2007117272A9 (fr) 2007-12-06
WO2007117272A3 true WO2007117272A3 (fr) 2008-07-31

Family

ID=38581510

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/038164 Ceased WO2007117272A2 (fr) 2005-09-30 2006-10-02 Méthodes de traitement d'un choc hémorragique et de troubles associés

Country Status (2)

Country Link
EP (1) EP1940379A4 (fr)
WO (1) WO2007117272A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2519215C2 (ru) 2007-11-02 2014-06-10 Прометик Байосайенсиз Инк. Жирные кислоты и глицериды со средней длиной цепи в качестве нефропротективных средств
US9435813B2 (en) * 2010-05-11 2016-09-06 The General Hospital Corporation Biomarkers of hemorrhagic shock
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003070188A2 (fr) * 2002-02-15 2003-08-28 Sloan-Kettering Institute For Cancer Research Methode de traitement des maladies mediees par la thioredoxine (trx)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2394022C2 (ru) * 2002-03-04 2010-07-10 МЕРК ЭйчДиЭйСи Рисерч, ЛЛС Способы индукции конечной дифференцировки

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003070188A2 (fr) * 2002-02-15 2003-08-28 Sloan-Kettering Institute For Cancer Research Methode de traitement des maladies mediees par la thioredoxine (trx)

Also Published As

Publication number Publication date
WO2007117272A9 (fr) 2007-12-06
WO2007117272A2 (fr) 2007-10-18
EP1940379A4 (fr) 2009-05-13
EP1940379A2 (fr) 2008-07-09

Similar Documents

Publication Publication Date Title
WO2008029276A3 (fr) Compositions et procédés de traitement d'une maladie ophtalmique
WO2008127594A3 (fr) Procédés de traitement impliquant l'inhibition de pi3k-alpha au moyen d'inhibiteurs de type quinaxoline
WO2004093831A3 (fr) Combinaisons de vaccins cellulaires exprimant les cytokines
SG170044A1 (en) Ocular allergy treatments
WO2006060507A3 (fr) Procedes et compositions d'utilisation de composes immunomodulatoires pour le traitement des troubles d'immunodeficience
PT2383271E (pt) Aminoquinolonas como inibidores de gsk-3
WO2007112014A3 (fr) Nouvelles combinaisons thérapeutiques pour le traitement de la dépression
GB2442915B (en) Perylenequinone derivatives and uses thereof
WO2006113498A3 (fr) 2-amino-quinazolin-5-ones
WO2006017188A3 (fr) Traitement adjuvant d’antipsychotiques atypiques à base de memantine dans des cas de schizophrénie
WO2008033440A3 (fr) Traitement de maladies hyperprolifératives à l'aide d'anthraquinones
WO2008013986A3 (fr) Compositions et méthodes destinées à traiter ou à prévenir la phototoxicité oculaire
WO2007062093A3 (fr) Polytherapie pour le traitement du cancer
WO2006074265A3 (fr) Therapie combinee et compositions pharmaceutiques utilisees dans le traitement des troubles inflammatoires
WO2008070010A3 (fr) Rétablissement après une attaque
MXPA05010160A (es) Combinacion sinergistica que comprende roflumilast y un agente anticolinergico seleccionado a partir de sales de ipratropio, oxitropio y tiotropio para el tratamiento de enfermedades respiratorias.
WO2009015369A3 (fr) Composés qui inhibent l'activité de la bêta-sécrétase et procédés d'utilisation de ceux-ci
WO2007130501A3 (fr) Polythérapie pour traiter le cancer
WO2006086693A3 (fr) Dispositifs medicaux
WO2007016338A3 (fr) Utilisation d’inhibiteurs de la chk2 kinase pour le traitement du cancer
MX2021011289A (es) Composiciones que comprenden moduladores de isoenzima m2 muscular de piruvato cinasa pkm2 y metodos de tratamiento que usan las mismas.
WO2009047505A3 (fr) Traitement de mélanome
WO2007117272A3 (fr) Méthodes de traitement d'un choc hémorragique et de troubles associés
WO2007023072A3 (fr) Utilisation d'ambroxol pour traiter les infections a rhinovirus
WO2006078336A3 (fr) Compositions et methodes permettant de traiter et de prevenir des maladies hyperproliferatives

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06850512

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2006850512

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE